Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylitol Nasal Irrigation After FESS
NCT06108921Completed
- Sponsor
- Taichung Veterans General Hospital
- Start
- Feb 2020
- Primary completion
- Feb 2023
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of xylitol in chronic rhinosinusitis (CRS) (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoints: 22-item Sino-Nasal Outcome Test and Self-reported adverse events at 2 months. Started Feb 2020; status: completed.
02
Drugs
xylitol
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT06108921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06108921.